| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c21169 _d21169 |
||
| 001 | BD-DhNSU-21169 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064852.0 | ||
| 008 | 190403s1992 nyua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0824785673 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRS189 _b.B28 1992 |
| 100 | 1 | _aBanakar, Umesh V. | |
| 245 | 0 | 0 |
_aPharmaceutical dissolution testing / _cUmesh V. Banakar and William A Hanson |
| 260 |
_aNew York : _bMarcel Dekker, _cc1992. |
||
| 300 |
_aix, 437 p. : _bill. ; _c24 cm. |
||
| 490 | 1 | _aDrugs and the pharmaceutical sciences ; v. 49 | |
| 650 | 0 | _aDrugs | |
| 650 | 4 | _aSolubility | |
| 650 | 4 | _aTesting | |
| 700 | 1 | _aHanson, William A | |
| 942 |
_2lcc _cBK |
||